Mainz Biomed B. V. , a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics in human genetics.
Mainz Biomed Nv stock last closed at $1.55, down 0.64% from the previous day, and has decreased 86.66% in one year. It has underperformed other stocks in the Diagnostics & Research industry by 0.88 percentage points. Mainz Biomed Nv stock is currently +21.09% from its 52-week low of $1.28, and -89.23% from its 52-week high of $14.39.
At the moment, there are 4.09M MYNZ shares outstanding. The market capitalization of MYNZ is $6.34M. In the last 24 hours, 176,000 MYNZ shares were traded.
You need an online brokerage account in order to access the NASDAQ market and buy MYNZ shares.
In our opinion, eToro is the best place to buy stocks. Here's why:
Get $10 towards your purchase of shares by opening an account with eToro today. This offer is only for US users.
Open eToro AccountNow that you've chosen the right brokerage, you need to fill out some personal details so you are able to buy MYNZ today.
Now that you have created your account on the stock trading app, you can securely and quickly fund your account:
Watch this video walkthrough if you need help depositing funds into your brokerage account.
After you have identified the best place to buy Mainz Biomed Nv stock, it's absolutely critical to research their stock prior to buying, so you can wrap your head around the risk and upside.
WallStreetZen was designed to help everyday investors do better fundamental analysis.
You can see all of the due diligence checks on MYNZ's stock page.
Investors use a variety of different financial metrics, analyses, models, and charts to gauge MYNZ's intrinsic value.
Using relative valuations methods:
You can access more valuation research on MYNZ's stock here.
You can dive deeper into what analysts are projecting on the Mainz Biomed Nv stock forecast page.
Last year, MYNZ revenue was $659.94k. During the last four year, MYNZ's revenue has grown by -2.96% per year. This was slower than the Diagnostics & Research industry average of 9.47%.
Find out more about MYNZ's earnings and revenue performance here.
Over the last year, executives and large shareholders at MYNZ have not bought or sold any shares.
Dig into more about who owns MYNZ shares here.
No, Mainz Biomed Nv doesn't provide an income stream by paying out dividends.
One of the reasons eToro is our favorite brokerage is because of its social trading community.
Click below to learn what other community members have to say.
There are two primary order types:
Click the Open Trade button and your broker will place your order.
If you need additional help with investing in stocks on eToro, click the how to video below:
Now that you own some MYNZ stock, you'll want to stay up-to-date on your investment.
Create a watchlist to track the most important metrics related to your MYNZ stock.
To reiterate, here are the 6 steps for buying Mainz Biomed Nv stock:
If you are looking for a brokerage account, eToro is our recommended option.
Get Started with eToro TodayIf you would like to get the latest news on your investment in Mainz Biomed Nv, click below.